Search Results for: stroke recovery treatments 2013

UH Case Medical Center awarded highest certification as Comprehensive Stroke Center

Posted: Published on March 14th, 2013

Public release date: 13-Mar-2013 [ | E-mail | Share ] Contact: George Stamatis george.stamatis@uhhospitals.org 216-844-3667 University Hospitals Case Medical Center University Hospitals (UH) Case Medical Center has become the first hospital in Northeast Ohio and 19th in the nation to achieve The Joint Commission's standards for Comprehensive Stroke Center Certification, joining an elite group of providers focused on complex stroke care. Comprehensive stroke centers are recognized as industry leaders and are responsible for setting the national agenda in all aspects of stroke care and prevention. The recognition comes from The Joint Commission, the nation's oldest and largest standards-setting and accrediting body in health care, and the American Heart Association/American Stroke Association. Comprehensive Stroke Center Certification recognizes those hospitals that have state-of-the-art infrastructure, staff and training to receive and treat patients with the most complex strokes. UH Case Medical Center underwent a rigorous onsite review in November. Joint Commission experts reviewed UH Case Medical Center's compliance with the Comprehensive Stroke Center standards and requirements including advanced imaging capabilities, 24/7 availability of specialized treatments, and staff with the unique education and competencies to care for complex stroke patients. "By achieving this advanced certification, University Hospitals Case Medical Center has thoroughly demonstrated the … Continue reading

Comments Off on UH Case Medical Center awarded highest certification as Comprehensive Stroke Center

New Stroke Guidelines Stress Treatment Within One Hour of Arrival in ER

Posted: Published on February 2nd, 2013

Steven Reinberg HealthDay Reporter Posted: Friday, February 1, 2013, 10:16 AM THURSDAY, Jan. 31 (HealthDay News) -- New guidelines on stroke care stress that getting clot-busting drugs and other treatments within one hour of arriving in the emergency room is crucial to minimizing brain damage and speeding recovery. "We have incorporated a lot of learning and experience in the past five years in developing stroke systems of care," said guideline author Dr. Edward Jauch, director of the division of emergency medicine at the Medical University of South Carolina, in Charleston. "It's not just a single person managing a stroke that makes a difference. It's creating a process that involves patients, people around patients, pre-hospital care and hospitals," he said. "When all these pieces are in place, the patient has the best chance for having a good outcome." The new guidelines, from the American Stroke Association, were published online Jan. 31 and will appear in the March print issue of the journal Stroke. The most common type of stroke, called an ischemic stroke, is caused by a blood clot in an artery in the brain. Ischemic strokes account for 90 percent of all strokes. Once doctors determine that a patient is … Continue reading

Comments Off on New Stroke Guidelines Stress Treatment Within One Hour of Arrival in ER

Mercy Named One of Nation's First Fifteen Nationally Certified Stroke Centers

Posted: Published on February 1st, 2013

Mercy Hospital Oklahoma City is one of only 15 nationwide medical centers to earn The Joint Commission's Advanced Certification for Comprehensive Stroke Centers Oklahoma City, OK (PRWEB) January 31, 2013 What does this Advanced Comprehensive Stroke Center Certification mean to patients? It means Mercy has been recognized by the U.S. health care industrys most thorough standard-setting organization for having staff, equipment and processes that meet the highest levels of stroke prevention, detection, treatment and rehabilitation. With stroke, everyone knows minutes matter. What people might not know or think about when stroke happens is where they should go for their best chances of recovery, said Dr. Richard Vertrees Smith, neurosurgeon and Mercy NeuroScience Institute medical director. Were hoping this certification gives us the opportunity to help people in Oklahoma understand that the nations highest quality stroke care is right here at home, at Mercy. The process for earning this status started back in 2008, when Mercy earned its first stroke center accreditation from The Joint Commission the nations oldest and largest accrediting body in health care and didnt stop there. After a demanding application process, Mercy underwent a rigorous onsite review in October 2012, when Joint Commission experts surveyed compliance with … Continue reading

Comments Off on Mercy Named One of Nation's First Fifteen Nationally Certified Stroke Centers

Stroke Recovery Aided by Stem Cells, Study Shows

Posted: Published on January 30th, 2013

A new study has shown that stem cells may aid recovery in rats that have suffered a stroke. The study, published in the journal Stem Cell Research & Therapy, found that stem cell treatments improved the amount of brain and nerve tissue that was repaired and increased the ability of the rats to complete behavioral tasks. Researchers used stem cells from both bone-marrow and fat tissue, and found positive results for each. Improved recovery was seen regardless of origin of the stem cells, which may increase the usefulness of this treatment in human trials, said Dr. Exuperio Dez-Tejedor, principal investigator in the neurology department at La Paz University Hospital. Adipose-derived cells in particular are abundant and easy to collect without invasive surgery. Though this type of research is promising for human patients, the researchers stated that questions regarding treatment protocols and which types of stem cells to use still need to be answered. The rats in the study were injected with stem cells or saline 30 minutes after suffering a stroke. 24 hours after the stroke, the rats treated with stem cells had already shown a better recovery. Two weeks later the stem cell-treated rats had nearly normal scores on … Continue reading

Comments Off on Stroke Recovery Aided by Stem Cells, Study Shows

Stroke Survivor Embraces Post-Stroke Life and Mobility Challenges in Latest Faces of Stroke(SM) Campaign in Honor of …

Posted: Published on January 7th, 2013

CENTENNIAL, Colo., Jan. 7, 2013 /PRNewswire-USNewswire/-- Julie Hyman, 51, had a stroke at age 37. At the time, she was busy juggling home, family and work, but her lifestyle was stressful in the midst of balancing everything. Like so many people, she ignored the warning signs of her stroke, feeling that she was too young to experience such a devastating event. After her stroke, Julie felt that her life as she knew it was over. She was paralyzed on the left side and only had the use of one hand. She also had spasticity, a condition in which muscles become tight and stiff, making movement difficult or uncontrollable. "Relearning how to do simple things like buttoning my shirt were major challenges. Washing dishes, doing laundry and preparing meals were almost impossible," said Julie, a Faces of Stroke(SM) Ambassador for National Stroke Association's January mini-campaign honoring International Quality of Life Month. Nearly 60 percent of stroke survivors experience spasticity, which significantly affects their quality of life. Spasticity is a condition in which muscles become tight and stiff, which makes movement, especially of the arms or legs, difficult or uncontrollable. Through rehabilitation and therapy, Julie was taught to "think-plan-act" for every action … Continue reading

Comments Off on Stroke Survivor Embraces Post-Stroke Life and Mobility Challenges in Latest Faces of Stroke(SM) Campaign in Honor of …

Key Takeaways from the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure – AJMC.com Managed Markets Network

Posted: Published on August 1st, 2022

The American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Failure Society of America (HFSA) recently published an updated clinical practice guideline for the management of heart failure (HF).1 This 2022 guideline consolidates and replaces the 2013 American College of Cardiology Foundation (ACCF)/AHA guideline for HF management and its subsequent 2017 focused update, which was developed by the ACC/AHA/HFSA.1,2 As it emphasizes both the importance of applying clinical judgement and a shared decision-making approach, the 2022 guideline outlines management recommendations based upon up-to-date evidence.1 Focusing on HF prevention, management strategies, and implantable devices, the guideline addresses new recommendations for treatments (eg, for sodium-glucose cotransporter-2 [SGLT2] inhibitors, angiotensin receptor-neprilysin inhibitors [ARNIs]), atrial fibrillation (AF) management, management strategies specific to cardiac amyloidosis and cardio-oncology, and the use of left ventricular (LV) assist devices.1 This article reviews key takeaways from the 2022 guideline and summarizes the guidelines new recommendations for SGLT2 inhibitor therapy. The 2022 HF guideline emphasizes the need for primary prevention, which may help mitigate the health and economic burden associated with HF, which is projected to spread to 2.97% of the US population by 2030.1,3 To address this need, guideline authors revised the stages of HF to emphasize those who are at risk, and highlighted the evolving role that structural cardiac changes and biomarkers play in identifying at-risk patients.1 These patients are potential candidates for preventive targeted treatment strategies. Continue reading

Posted in Vascular Biology | Comments Off on Key Takeaways from the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure – AJMC.com Managed Markets Network

Anxiety and Depression in Patients with Primary Biliary Cholangitis: C | HMER – Dove Medical Press

Posted: Published on August 28th, 2021

Correspondence: Kris V Kowdley Liver Institute Northwest, 3216 NE 45th Pl, Suite 212, Seattle, WA, 98105, Tel +1 206-536-3030 Fax +1 206-524-0749 Email [emailprotected] Abstract: Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic cholestatic immune-mediated liver disease characterized by injury to intrahepatic bile ducts that may ultimately progress to cirrhosis and liver failure and result in the need for liver transplant or death without treatment. Ursodeoxycholic acid (UDCA) and obeticholic acid (OCA) are approved therapies for PBC and are associated with a reduced risk of progression of disease, although patients may continue to experience significant symptoms of pruritus and fatigue independent of liver disease Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Anxiety and Depression in Patients with Primary Biliary Cholangitis: C | HMER – Dove Medical Press

[Full text] Association Between Depression and Hospital Length of Stay | RMHP – Dove Medical Press

Posted: Published on April 13th, 2021

Introduction Cardiovascular diseases (CVDs) remain the main cause of death worldwide,1 and over two-thirds of these deaths occur in developing countries.2 One of the most common CVDs is Coronary Heart Disease (CHD),3 and its treatments and controlling factors affecting outcomes are of fundamental significance for health systems. Coronary Artery Bypass Graft Surgery (CABG) is the most appropriate management for CHD when less invasive medical options are not appropriate. CABG is a common surgery for those patients because of its beneficial outcomes.36 This is evident as nearly one million CABG surgeries were done worldwide since more than ten years ago.6 Successful CABG outcomes include improved patient well-being and efficient status, reduced signs and symptoms of disability, decreased anxiety and depressive symptoms (DS), and improved quality of life.4,5,7,8 Nevertheless, CABG itself is a worrying and disturbing incident for patients, known to be accompanied by undesirable psychosomatic results in both the preoperative and postoperative periods.9,10 Furthermore, some negative consequences following this surgery remain unresolved.4,6,11,12 For example, more than a third of patients complain of chest pain, and roughly half of them have activity restriction one year later.11 Thus, recognizing changeable associated factors contributing to these adverse outcomes might improve patients reaction after CABG Continue reading

Posted in Coronary Heart Diseases | Comments Off on [Full text] Association Between Depression and Hospital Length of Stay | RMHP – Dove Medical Press

[Full text] L-Cysteine Provides Neuroprotection of Hypoxia-Ischemia Injury in Neon | DDDT – Dove Medical Press

Posted: Published on February 16th, 2021

Introduction Neonatal hypoxia-ischemia (HI) brain injury is associated with mortality or severe neurological disabilities.1 Accordingly, understanding of the pathologic and survival mechanisms of HI injury on brain functions represents a critical area of investigation for the development of neuroprotective treatments. Hydrogen sulfide (H2S) has been reported to be involved in modulating physiological and pathological processes within the central nervous systems.2,3 Normally, in mammalian cells, H2S originates from the metabolism of L-Cysteine through catalysis involving three enzymes, cystathionine--synthase (CBS), cystathionine--lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3MST). These H2S-producing enzymes are highly expressed in various types of tissue and cells, including the brain.4 An exogenous administration of H2S has been shown to exert a neuroprotective effect through its capacity to affect anti-apoptotic, anti-inflammatory and anti-oxidative functions.5,6 Recently, we reported that L-Cysteine was able to suppress HI-induced microglial activation and neuroinflammation by releasing H2S.7,8 Although these reports indicate neuroprotective effects of H2S, the underlying mechanisms of this neuroprotection against brain damage resulting from HI have not been fully elucidated Continue reading

Posted in Brain Injury Treatment | Comments Off on [Full text] L-Cysteine Provides Neuroprotection of Hypoxia-Ischemia Injury in Neon | DDDT – Dove Medical Press

Amyotrophic Lateral Sclerosis Treatment Market, Market Research and Industry Forecast Report, 2026 (Includes Business Impact of COVID-19) – Eurowire

Posted: Published on October 21st, 2020

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Amyotrophic Lateral Sclerosis Treatment market. Trusted Business Insights presents an updated and Latest Study on Amyotrophic Lateral Sclerosis Treatment Market. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors Continue reading

Posted in ALS Treatment | Comments Off on Amyotrophic Lateral Sclerosis Treatment Market, Market Research and Industry Forecast Report, 2026 (Includes Business Impact of COVID-19) – Eurowire